Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
BeOne Medicines
BeOne Medicines
Thomas Jefferson University
AVM Biotechnology Inc
BeOne Medicines
Nurix Therapeutics, Inc.
Janssen Research & Development, LLC
Calibr, a division of Scripps Research
Genmab
Vironexis Biotherapeutics Inc.
University Hospital, Angers
AbbVie
AstraZeneca
National Institutes of Health Clinical Center (CC)
Nurix Therapeutics, Inc.
MEI Pharma, Inc.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Galapagos NV
Masonic Cancer Center, University of Minnesota
Merck Sharp & Dohme LLC
BeOne Medicines
University of Chicago
University of Washington
Tempus AI
Fred Hutchinson Cancer Center
Medical College of Wisconsin
BeOne Medicines
Ascentage Pharma Group Inc.
Children's Hospital Medical Center, Cincinnati
Essen Biotech
Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS
Newave Pharmaceutical Inc
Schrödinger, Inc.
Mayo Clinic
Emory University
AIDS Malignancy Consortium
City of Hope Medical Center
iOMEDICO AG
Eli Lilly and Company
University of Michigan Rogel Cancer Center
AbbVie
University of California, San Francisco
Fred Hutchinson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
Carna Biosciences, Inc.
National Cancer Institute (NCI)
City of Hope Medical Center
BeOne Medicines